March 23 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said its net profit increased 13.9% on the year in 2022, reaching 13.9 million marka ($7.7 million/7.1 million euro).
Total revenue went up 33.4% year-on-year to 202 million marka, whereas total expenses rose 34% to 184.3 million marka, Bosnalijek said in a filing to the Sarajevo Stock Exchange (SASE) on Wednesday.
The company's shares closed flat at 28.5 marka on the SASE on Wednesday. They did not trade by 9:50 CET on Thursday.
Bosnalijek is the largest pharmaceuticals company in Bosnia and Herzegovina.
(1 euro = 1.95583 marka)